Pharma Equity Group A/S (CPH: PEG)
Denmark
· Delayed Price · Currency is DKK
0.213
-0.023 (-9.75%)
Oct 2, 2024, 4:51 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 214.82 million as of October 3, 2024. Its market cap has decreased by -45.88% in one year.
Market Cap
214.82M
Enterprise Value
257.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 214.82M, a decrease of -72.00%. That is a compound annual growth rate of -56.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2024 | 214.82M | -51.16% |
Dec 29, 2023 | 439.87M | -42.67% |
Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Novo Nordisk A/S | 3,477.74B |
Coloplast A/S | 196.96B |
Genmab A/S | 101.20B |
Zealand Pharma A/S | 57.86B |
Demant A/S | 56.39B |
H. Lundbeck A/S | 41.69B |
H. Lundbeck A/S | 41.69B |
ALK-Abelló A/S | 37.58B |